Global TCR Engineered T-Cell Therapy Technologies, Pipelines, Stakeholders & Deals Report 2018 – GlobeNewswire (press release)
|
Global TCR Engineered T–Cell Therapy Technologies, Pipelines, Stakeholders & Deals Report 2018
GlobeNewswire (press release) Both receptors deploy T-cells to target the tumor, but CAR T-cells (CAR-T) are limited to binding to cell surface antigens, while TCR T-cells (TCR-T) recognize peptides (derived from intracellular proteins) presented on the cell surface by the major … |
